These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 405519)

  • 1. A comparative study of the anti-allergic effects of disodium baicalein 6-phosphate (BPS) and disodium cromoglycate (DSCG).
    Koda A; Watanabe S; Yanagihara Y; Nagai H; Sakamoto K
    Jpn J Pharmacol; 1977 Feb; 27(1):31-8. PubMed ID: 405519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of homologous passive cutaneous anaphylaxis (PCA) by disodium cromoglycate-related compounds.
    Koda A; Sakamoto K; Yanagihara Y
    Jpn J Pharmacol; 1980 Aug; 30(4):437-47. PubMed ID: 6162986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of disodium cromoglycate on mast cell-mediated immediate-type allergic reactions.
    Shin HY; Kim JS; An NH; Park RK; Kim HM
    Life Sci; 2004 Apr; 74(23):2877-87. PubMed ID: 15050425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of immediate hypersensitivity reactions in the rat by disodium cromoglycate and nitroindanedione.
    Spicer BA; Ross JW; Smith H
    Clin Exp Immunol; 1975 Sep; 21(3):419-29. PubMed ID: 812623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiallergic/antiasthmatic effect of novel antiallergic hexapeptide-95/220 in various experimental models.
    Singh R; Nath A; Gupta PP; Shukla M; Khare SK; Kundu B
    Indian J Exp Biol; 2001 Sep; 39(9):871-7. PubMed ID: 11831367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
    Nabe T; Yamamura H; Kohno S; Ohata K
    Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [[Effect of traxanox sodium on type I-IV allergic reactions. Studies on anti-allergic agents VII].
    Terasawa M; Goto K; Maruyama Y
    Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):417-27. PubMed ID: 6219052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of immediate hypersensitivity reactions in the rat by ICI 74,917 and disodium cromoglycate.
    Evans DP; Marshall PW; Thomson DS
    Int Arch Allergy Appl Immunol; 1975; 49(4):417-27. PubMed ID: 51008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of disodium cromoglycate on cutaneous basophil anaphylaxis.
    Golden HW; Crean GL; Iacuzio DA; Otterness IG
    J Immunol; 1986 Sep; 137(5):1495-503. PubMed ID: 2427571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An experimental asthma model in unanesthetized rat, and the difference in effect of disodium cromoglycate between passive cutaneous anaphylaxis model and asthma model in rat.
    Kuriyama K; Ichikawa K
    J Pharmacobiodyn; 1982 Oct; 5(10):751-9. PubMed ID: 6819356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of C5a-induced basophil degranulation by disodium cromoglycate.
    Golden HW; Iacuzio DA; Otterness IG
    Agents Actions; 1987 Aug; 21(3-4):371-4. PubMed ID: 2446479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 6-ethyl-3-(1H-tetrazol-5-yl)chromone (AA-344) on the immediate and delayed hypersensitivity reactions.
    Kuriki H; Saijo T; Ashida Y; Maki Y
    Jpn J Pharmacol; 1979 Oct; 29(5):733-44. PubMed ID: 161338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of hypersensitivity reactions by a new drug, N(3',4'-dimethoxycinnamoyl) anthranilic acid (N-5').
    Koda A; Nagai H; Watanabe S; Yanagihara Y; Sakamoto K
    J Allergy Clin Immunol; 1976 May; 57(5):396-407. PubMed ID: 131140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopharmacologic properties of WY-16, 922, a new orally effective antiallergic agent.
    Rosenthale ME; Begany AJ; Dervinis A; Sellstedt J; Guinosso C; Gluckman MI
    J Pharmacol Exp Ther; 1976 Jun; 197(3):725-33. PubMed ID: 58988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopharmacological studies on TBX, a new antiallergic drug (1). Inhibitory effects on passive cutaneous anaphylaxis in rats and guinea pigs.
    Yanagihara Y; Kasai H; Kawashima T; Shida T
    Jpn J Pharmacol; 1988 Sep; 48(1):91-101. PubMed ID: 2462074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release.
    Khandwala A; Coutts S; Pruss T; Jones H; Neiss E; Weinryb I
    Biochem Pharmacol; 1987 Mar; 36(5):663-72. PubMed ID: 2435293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of disodium cromoglycate on in vitro mast cell degranulation in human jejunal mucosa.
    Selbekk BH
    Allergy; 1979 Oct; 34(5):283-8. PubMed ID: 121046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-allergic activities of a new benzopyranopyridine derivative Y-12,141 in rats.
    Goto K; Terasawa M; Maruyama Y
    Int Arch Allergy Appl Immunol; 1979; 59(1):13-9. PubMed ID: 87373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunopharmacological study of buckwheat hypersensitivity (author's transl)].
    Yanagihara Y; Koda A
    Nihon Yakurigaku Zasshi; 1979 Jul; 75(5):459-75. PubMed ID: 94295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo immunopharmacologic properties of a new antiallergic agent RHC 3414.
    Khandwala A; Sonnino-Goldman P; Leibowitz M; Dally-Meade V; Donigi-Ruzza D
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):103-22. PubMed ID: 6202252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.